Partners to host joint conference on ‘Protein Sciences in Drug Discovery’ in Cambridge, UK from 18–19 November 2024.

Just – Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD’s Manufacturing Optimization Program.

Four new anti-idiotypic antibodies and a new anti-MMAE antibody range support bioanalytical assay development for preclinical research and clinical trials.

Study published in Bone Marrow Transplantation uses real-world clinical data to create virtual digital twin cohorts instead of placebo and standard-of-care comparator arms.

Investment of more than 50 million USD to meet growing global demand for drug and hydrophilic coatings for medical devices and components.

Zapnometinib is now ready for clinical development in severe influenza, an area without approved therapies and with a rapidly evolving pandemic threat from bird flu virus H5N1.

£790k FASST grant, in collaboration with DeepMirror, and £350k Engineering Biology grant awarded for platform development.

Milestone payment follows successful target identification and validation in separate project under same collaboration.

The new facility in Bleiswijk, Netherlands offers a comprehensive range of cold and ultra-cold services enabling global clinical trial innovation and biorepository storage solutions.

Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity.